Safety, tolerability and risk benefit analysis of tiotropium in COPD. - Wikidata - awgldk - TriplyDB

Safety, tolerability and risk benefit analysis of tiotropium in COPD.

Safety, tolerability and risk benefit analysis of tiotropium in COPD.

http://www.wikidata.org/entity/Q37115876

about

Ten years of tiotropium: clinical impact and patient perspectives Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007-2010.Optimizing safety of COPD treatments: role of the nurse practitioner.Safety and tolerability of inhalational anticholinergics in COPD A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD.Risk of cardiovascular events after initiation of long-acting bronchodilators in patients with chronic obstructive lung disease: A population-based study.A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence.

P2860

Q26823682-83341736-110D-4F20-A325-7941BC59FBFE Q28258219-1F15AD84-9FCE-47A0-97E8-B55ED2EDFEEB Q36421017-32B3F79E-F60C-4559-98B3-9E166BA1BA95 Q36539136-F34771FE-05F1-4291-B15A-730140DEBB49 Q36642198-25718DDE-8CFE-4DB4-873A-A781C3DA9418 Q36680246-691EDDF0-AD3C-4072-BA0A-CB295ECA420B Q37284894-6017C2C9-20F1-4267-9E59-872CD2FD3B2A Q37315758-8D6B7EF0-03B2-4182-92AD-5F79B06F3E2A Q37653402-4D5B6DEA-8555-444C-900A-E49D7E7EE134 Q43269192-FB8A49FC-2C4E-4FCB-8DEE-3A602AE66B9D

P2860

Safety, tolerability and risk benefit analysis of tiotropium in COPD.

http://www.wikidata.org/entity/Q37115876

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Safety, tolerability and risk benefit analysis of tiotropium in COPD.

@en

Safety, tolerability and risk benefit analysis of tiotropium in COPD.

@nl

type

label

Safety, tolerability and risk benefit analysis of tiotropium in COPD.

@en

Safety, tolerability and risk benefit analysis of tiotropium in COPD.

@nl

prefLabel

Safety, tolerability and risk benefit analysis of tiotropium in COPD.

@en

Safety, tolerability and risk benefit analysis of tiotropium in COPD.

@nl

P1433

Q37115876-7681DE5D-D27A-4A22-87E8-37F02C0BCFBE

P1476

Q37115876-F16C1B20-B9D7-4310-AD48-70366EE2B124

P2093

Q37115876-682D7AE9-F2F7-4F0F-95C0-E469C59E4928

Q37115876-96B54F13-AE73-49F1-96B1-66F7432656CF

Q37115876-E76773BD-200D-4958-84E0-1810E772B099

P2860

Q37115876-03750B6E-DFEC-4206-9D4C-225063AA1AFE

Q37115876-0EE199A0-6637-4839-8EFD-D7DCD65CC7AE

Q37115876-176E418B-C4BE-4187-868A-5D63348BDE68

Q37115876-17F4B015-D299-4826-A0D2-C3B392FC4D59

Q37115876-1923C688-EAFF-4FA1-BFA3-7A35968EBF2D

Q37115876-1B3EBA23-6054-4868-B831-3A6AEAE78760

Q37115876-1C38EA00-A109-49AC-9F60-653DBA96799D

Q37115876-2926D3DD-2266-45C4-951F-D6DC5DFB838F

Q37115876-29FFB3B9-3310-40B3-894A-7F17F1137370

Q37115876-2B48219F-576F-44C9-851B-F48917ADB4A5

P304

Q37115876-7CF6B797-5DEF-4395-A22D-A5E546CE021F

P31

Q37115876-17622D64-2550-469F-9B5A-6B179EA24A8F

Q37115876-187CF14E-D774-40E8-B005-19B56986C54C

P356

Q37115876-C9FD17FD-83AB-4C66-B047-77EDA9B4A246

P407

Q37115876-560FCCD8-264A-46D3-A1EF-8E07FBBE23B8

P433

Q37115876-145AE4CF-72BB-48E3-AD51-D979FBBE0B23

P478

Q37115876-243C3D3C-27B0-4B1E-9043-36AA48700F3C

P577

Q37115876-50C1D130-15F7-4303-8C12-3A59EC4B634C

P698

Q37115876-332851E6-FB6E-49AF-AC16-78BE39992259

P921

Q37115876-5DA622E4-B0FC-4C2C-82CE-9B0220837689

Q37115876-782D3BF3-2492-413C-A5FD-4547B25CD5CB

Q37115876-F00F54FB-11C4-454F-847F-1043A3FB884B

P932

Q37115876-6E09080B-3598-4EF8-8E4F-117A38522BB5

P356

P1433

International Journal of Chronic Obstructive Pulmonary Disease

P1476

Safety, tolerability and risk benefit analysis of tiotropium in COPD.

@en

P2093

Danish M Thameem

http://www.w3.org/2001/XMLSchema#string

Tareq Zaza

http://www.w3.org/2001/XMLSchema#string

Yuji Oba

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.

The effect of tiotropium on exacerbations and airflow in patients with COPD.

The pharmacological properties of tiotropium.

Short-acting beta 2 agonists for stable chronic obstructive pulmonary disease.

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial.

P304

575-584

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S3530

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19281075

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

mechanism of action

P932

2650597

http://www.w3.org/2001/XMLSchema#string